Unknown NA INTERVENTIONAL 3-arm NCT04929509

P11-4 and Nanosilver Fluoride Varnish in Treatment of White Spot Carious Lesions

Effectiveness of Self-assembling Peptide (P11-4) and Nano-silver Fluoride Varnish in Management of Enamel White Spot Lesions in Young People (Randomized Controlled Clinical Trial)

Sponsor: Hams Hamed Abdelrahman

Conditions White Spot Lesion

Interventions nanosilver fluoride varnish self-assembling peptide sodium fluoride varnish

Updated 4 times since 2021 Last updated: Jun 15, 2021 Started: Dec 5, 2020 Primary completion: Oct 5, 2021 Completion: Jan 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04929509, this NA trial focuses on White Spot Lesion and remains ongoing. Sponsored by Hams Hamed Abdelrahman, it has been updated 4 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jul 2023 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Sep 2021 — Jul 2023 [monthly]

Recruiting NA

First recorded

Dec 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hams Hamed Abdelrahman

Data source: Alexandria University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Alexandria, Egypt